Shanghai Orsin Medical Technology Co., Ltd. miaomiao8615@orsins.com 86-021-57450666
Cap Color | Additive | Sample Type | Primary Applications | Key Considerations |
---|---|---|---|---|
Red | None/Clot activator | Serum | Routine biochemistry (liver/kidney function), immunology tests (tumor markers, hepatitis/HIV), blood bank testing | Clot activator accelerates coagulation. For emergencies, use orange-red tubes. |
Gold | Inert gel separator + Clot activator | Serum | Emergency biochemistry (cardiac enzymes, thyroid function), therapeutic drug monitoring | Gel barrier separates cells from serum; stable for ≤48 hours. |
Green | Sodium/Lithium heparin | Plasma/Whole blood | Electrolytes, blood gas analysis, hemorheology studies | CONTRAINDICATED for WBC count (heparin causes cell clumping). |
Light Green | Lithium heparin + Inert gel | Plasma | Emergency plasma tests (e.g., ICU), electrolyte analysis | Rapid plasma separation minimizes cellular contamination. |
Lavender (Purple) | EDTA (K₂/K₃) | Whole blood | CBC, blood typing, HbA1c | CONTRAINDICATED for coagulation/calcium/potassium tests (EDTA chelates ions). |
Light Blue | Sodium citrate (3.2%~3.8%) | Plasma | Coagulation studies (PT, APTT, fibrinogen) | Strict 1:9 blood-to-anticoagulant ratio required; underfilling alters results. |
Black | Sodium citrate (3.2%) | Whole blood | Erythrocyte sedimentation rate (ESR) | Fixed 1:4 anticoagulant-to-blood ratio; excess anticoagulant dilutes samples. |
Gray | Sodium fluoride + Potassium oxalate | Plasma/Whole blood | Glucose testing (inhibits glycolysis) | CONTRAINDICATED for urease-based urea assays; may interfere with enzymatic tests. |
Royal Blue | Heparin/EDTA (trace-element-free) | Serum/Plasma | Trace element/toxicology testing (e.g., blood lead) | Uses ultrapure materials to avoid trace-element contamination. |